首页> 外文OA文献 >Cost-benefit analysis of endocrine therapy in the adjuvant setting for postmenopausal patients with hormone receptor-positive breast cancer, based on survival data and future prices for generic drugs in the context of the German health care system

【2h】

Cost-benefit analysis of endocrine therapy in the adjuvant setting for postmenopausal patients with hormone receptor-positive breast cancer, based on survival data and future prices for generic drugs in the context of the German health care system

机译：基于生存数据和德国医疗保健系统中仿制药的未来价格，对激素受体阳性乳腺癌绝经后患者的辅助治疗内分泌治疗进行成本效益分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Michael P. Lux, Claudia Reichelt, Jon Karnon, Thorsten D. Tänzer, Dragan Radosavac, Peter A. Fasching, Matthias W. Beckmann, Falk C. Thiel

机译：Michael P. Lux，Claudia Reichelt，Jon Karnon，ThorstenD.Tänzer，Dragan Radosavac，Peter A.Fasching，Matthias W.Beckmann，Falk C.Thiel

著录项

作者
Lux, M.; Reichelt, C.; Karnon, J.; Tanzer, T.; Radosavac, D.; Fasching, P.; Beckmann, M.; Thiel, F.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-Benefit Analysis of Endocrine Therapy in the Adjuvant Setting for Postmenopausal Patients with Hormone Receptor-Positive Breast Cancer, Based on Survival Data and Future Prices for Generic Drugs in the Context of the German Health Care System [J] . Michael P. Lux, Claudia Reichelt, Jon Karnon, Breast care . 2011,第5期

机译：基于生存数据和德国医疗体系中仿制药的未来价格，对绝经后激素受体阳性乳腺癌绝经后患者辅助治疗中内分泌治疗的成本效益分析
2. Cost-Benefit Analysis of Endocrine Therapy in the Adjuwant Setting for Postmenopausal Patients with Hormone Receptor-Positiwe Breast Cancer, Based on Surwiwal Data and Future Prices for Generic Drugs in the Context of the German Health Care System [J] . Michael P. Lux, Claudia Reichelt, Jon Karnon, Breast care . 2011,第5期

机译：在德国医疗保健体系的背景下，根据Surwiwal数据和仿制药的未来价格，对绝经后激素受体-Positiwe乳腺癌绝经后患者辅助治疗中的内分泌治疗进行了成本效益分析
3. Use of adjuvant endocrine therapy in postmenopausal hormone receptor-positive breast cancer at German breast cancer centers and university hospitals-results of an enquiry (adjuvant endocrine therapy enquiry) [J] . KolbenT., EngelmannS., MaurerS., Breast care . 2012,第1期

机译：辅助内分泌疗法在德国乳腺癌中心和大学医院的绝经后激素受体阳性乳腺癌中的应用-咨询结果（辅助内分泌疗法咨询）
4. Availability and Usability of the Hospital-based Cancer Registry Data for Measuring the Quality Outcome Indicators of Healthcare Provided to Breast and Colorectal Cancer Patients at King Hussein Cancer Center [C] . Amid Abu Hmaidan, Elsie Boutou, Khaled Jamal, International Conference on Cancer Care Informatics . 2018

机译：基于医院的癌症登记系统数据的可用性和可用性，用于测量侯赛因国王癌症中心提供给乳腺癌和结直肠癌患者的医疗保健质量结果指标
5. A comparative analysis of data security in computer-based and paper-based patient record systems from the perceptions of healthcare providers in major hospitals in Saudi Arabia. [D] . Maghazil, Mohammed. 2004

机译：根据沙特阿拉伯主要医院的医疗保健提供者的看法，对基于计算机和基于纸张的患者记录系统中数据安全性进行了比较分析。
6. Cost-Benefit Analysis of Endocrine Therapy in the Adjuvant Setting for Postmenopausal Patients with Hormone Receptor-Positive Breast Cancer Based on Survival Data and Future Prices for Generic Drugs in the Context of the German Health Care System [O] . Michael P. Lux, Claudia Reichelt, Jon Karnon, 2011

机译：根据生存数据和德国医疗体系中仿制药的未来价格对绝经后激素受体阳性乳腺癌绝经后患者辅助治疗中的内分泌治疗进行成本效益分析
7. Use of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer at German Breast Cancer Centers and University Hospitals - Results of an Enquiry (Adjuvant Endocrine Therapy Enquiry) [O] . Thomas Kolben, Susanne Engelmann, Susanne Maurer, 2012

机译：在德国乳腺癌中心和大学医院的绝经后激素受体阳性乳腺癌中使用辅助内分泌治疗 - 询问结果（佐剂内分泌治疗查询）

Cost-benefit analysis of endocrine therapy in the adjuvant setting for postmenopausal patients with hormone receptor-positive breast cancer, based on survival data and future prices for generic drugs in the context of the German health care system

摘要

著录项

相似文献

相关主题

期刊订阅